poster
Analysis of Editorial Board Gender Parity of the Top 20 Most Influential Dermatology Journals
keywords:
and scientometrics
informatics
editorial and peer review process
diversity and inclusion
bibliometrics
Objective Women continue to be underrepresented in
academic leadership positions, especially in dermatology.1
Although women account for more than half of all board-
certified dermatologists in the United States, academic
dermatology leadership roles, such as department chair and
fellowship director positions, remain disproportionately
occupied by men.2 Available evidence suggests that this
inequity extends to medical journals, with substantial gender
gaps reported in editorial board composition across multiple
specialties. Previously published data from 2018 suggested
that women accounted for the minority of dermatology
editors in all positions.1 To provide an update to this work and
an evaluation of current trends, the gender distribution of
dermatology editorial boards was assessed in 2021, making
comparisons among the top 20 most influential dermatology
journals.
Design The top 20 dermatology journals by 2020 h-index
were identified on Scimago.3 Journal editorial board websites
were searched in November 2021 for lists of editor names and
roles, and journal-defined editorial board members were
collected and tabulated. Binary (women vs men) gender
estimation by author first name was performed with Gender
API, a popular gender inference service based on querying
large multifactorial databases and name repositories.
Estimations were corroborated by online searches of
professional photographs and biographies by 2 independent
reviewers, with in-depth discussion and consensus meetings
to resolve discrepancies.
Results Women made up a mean (SD) of 37% (12%) and a
median (IQR) of 33% (18%) of editorial boards across the top
20 dermatology journals (Table 32). The Journal of
Dermatological Science (15%) and Journal of the European
Academy of Dermatology and Venereology (22%) had the
lowest proportion of women editors, while Contact
Dermatitis (58%), Sexually Transmitted Infections (54%),
and Sexually Transmitted Diseases (53%) had among the
highest. The editorial board of JAMA Dermatology was
observed to be 56% women after excluding International
Advisory Committee members. Of the 20 journals, 5 journals
(25%) had women editors in chief.
Conclusions This study found that underrepresentation of
women on dermatology journal editorial boards persisted
across multiple top journals. The finding suggests that editors
in chief and journal leadership should consider establishing
board member recruitment targets with the goal of gender
parity. A target of 50% women on boards could more
accurately represent the dermatology workforce. Limitations
of our study include reliance on high-throughput software
analyzing first names only and estimating binary gender,
which may lead to misclassification. Future work should
consider self-reported sex and gender identity to ensure true
concordance with the individual’s identity. Addressing gender
gaps and encouraging diversity of identity and perspectives
among editorial boards is a worthwhile goal for further
research.
References
1. Lobl M, Grinnell M, Higgins S, Yost K, Grimes P, Wysong
A. Representation of women as editors in dermatology
journals: a comprehensive review. Int J Womens Dermatol.
2019;6(1):20-24. doi:10.1016/j.ijwd.2019.09.002
2. Nambudiri VE, Shi CR, Vleugels RA, Olbricht SM.
Academic dermatology leadership in the United States—
addressing the gender gap. Int J Womens Dermatol.
2018;4(4):236-237. doi:10.1016/j.ijwd.2018.05.003
3. SJR Scimago Journal & Country Rank. Accessed November
30, 2021. https://www.scimagojr.com/journalrank.php
Conflict of Interest Disclosures Robert P. Dellavalle is a joint
coordinating editor for Cochrane Skin, a dermatology section editor
for UpToDate, a social media editor for the Journal of the American
Academy of Dermatology, a podcast editor for the Journal of
Investigative Dermatology, editor in chief of JMIR Dermatology,
and a coordinating editor representative on Cochrane Council.
Torunn E. Sivesind serves as an editorial board member at large for
JMIR Dermatology and receives fellowship funding from Pfizer.
The remaining authors have no conflicts of interest to declare.